Prostate cancer screening in Brazil: Should it be done or not?

Wilson F S Busato, Gilberto L. Almeida

Research output: Contribution to journalReview articlepeer-review


The use of PSA in the screening, detection and prognosis of prostate cancer (PCa) has revolutionized the diagnosis and treatment of this disorder with an increase in detection rates and PCa organ-confined. Despite these benefits and ease of implementation, tracking PCa remains a matter of great controversy. We conducted a literature review and demographic and epidemiological data in Brazil feeling to assess the current state of screening and whether there is justification for population programs. the differences are valued between developed and underdeveloped countries as the incidence, mortality, screening and access to health. an analysis of the advantages and disadvantages of screening is made as well as a critical analysis of existing studies on screening and some recommendations on a rational screening.

Original languageEnglish
Pages (from-to)1069-1080
Number of pages12
JournalInternational Braz J Urol
Issue number6
Publication statusPublished - 2016


  • Brazil
  • Mass screening
  • Prostatic neoplasms

ASJC Scopus subject areas

  • Urology


Dive into the research topics of 'Prostate cancer screening in Brazil: Should it be done or not?'. Together they form a unique fingerprint.

Cite this